Lymphocytes rolling on high endothelial venules stop abruptly in response to chemokines presented by endothelial cells, according to a report published online in Nature Immunology today (April 18).

Mesenchymal stem cells (MSC) represent a promising therapeutic approach in many diseases in view of their potent immunomodulatory properties, which are only partially understood. Here, we show ...